Two River Group Holdings

Two River is a prominent venture capital and merchant bank firm focused on the life sciences sector, particularly in the development of transformative cell and gene therapies. Founded by a team of experienced industry veterans, the firm operates as a company builder, providing the strategic vision and capital necessary to launch and scale high-impact biotech entities. Notable successes include the founding of Kite Pharma, which was acquired by Gilead Sciences, and the launch of Allogene Therapeutics and UroGen Pharma. Two River continues to shape the oncology and urology landscapes through its hands-on management and investment in cutting-edge therapeutic modalities.